Who
Samantha Truex
Director
Company insider
Files Form 4 as: Director, Avalo Therapeutics.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Aug 2024
- Last trade
- 2 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jun 2026filed 4 Jun 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,100 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,100 at $0.00 | filing |
| 28 Mar 2026filed 31 Mar 2026 | AVTX Avalo TherapeuticsBiotechnology | SEC FORM 4 Code M | —3,166 | filing |
| 28 Mar 2026filed 31 Mar 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,166 at $0.00 | filing |
| 28 Mar 2026filed 31 Mar 2026 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,166 at $0.00 | filing |
| 28 Mar 2026filed 31 Mar 2026 | AVTX Avalo TherapeuticsBiotechnology | SEC FORM 4 Code M | —3,166 | filing |
| 17 Jun 2025filed 18 Jun 2025 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,100 at $0.00 | filing |
| 28 Mar 2025filed 1 Apr 2025 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,167 at $0.00 | filing |
| 28 Mar 2025filed 1 Apr 2025 | AVTX Avalo TherapeuticsBiotechnology | SEC FORM 4 Code M | —3,167 | filing |
| 13 Aug 2024filed 14 Aug 2024 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,600 at $0.00 | filing |
| 13 Aug 2024filed 14 Aug 2024 | AVTX Avalo Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.